A recap of the top headlines from Contemporary OB/GYN in September 2026, spanning ACOG's respiratory vaccine guidance to the launch of the Missed & Dismissed podcast.
|Articles|August 3, 2011
Transdermal Hormonal Contraception
Author(s)Aboubakr Elnashar, MD
Advertisement
Advertisement
Related to this article
A recap of Contemporary OB/GYN's top FDA and regulatory news from September 2026.
Anita Nelson, MD, discusses the FDA's approval extending etonogestrel implant use to 5 years and the new REMS certification clinicians must complete by February 23, 2027.
FDA accepted for review an sNDA for MIUDELLA copper IUD for a 6-year duration, with a PDUFA date in Q2 2027.
Advertisement
Advertisement
Trending on Contemporary OB/GYN
1
Wen Shen, MD, highlights pregnancy, comorbidity history in perimenopause care
2
IMS: Fezolinetant's improvements in sleep quality, hot flashes as early as week 4
3
Top headlines in women's health from September 2026
4
FAQ: What does the rename from PCOS to PMOS mean for your patients?
5